Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Mol Genet Metab. 2023 Nov;140(3):107649. doi: 10.1016/j.ymgme.2023.107649. Epub 2023 Jul 5.
Glomerular filtration rate (GFR) is commonly used in clinical practice for the diagnosis and follow-up of chronic kidney disease. Screening for inborn errors of metabolism (IEM) is based on analysis of biomarkers in urine, reported by their ratio to urinary creatinine (crn). Impaired renal function may complicate the interpretation of several biomarkers used for screening of IEM. Our goal was to investigate the influence of kidney function, in terms of measured GFR (mGFR) on purines and pyrimidines in urine, in addition to the relationship to sex, age, pH and ketosis. Children (n = 96) with chronic kidney disease (CKD), in different CKD stages, were included. Urine samples were obtained prior to the injection of iohexol. Serum samples at 7 time-points were used to calculate mGFR based on iohexol plasma clearance. The association with sex, age, ketosis and pH was examined in samples of the laboratory production from 2015 to 2021 (n = 8192). Age was a highly significant covariate for all markers. GFR correlated positively to several purines and pyrimidines; the ratios hypoxanthine/crn, xanthine/crn and urate/crn (p = 2.0 × 10, < 3 × 10 and 7.2 × 10, respectively), and the ratios orotic acid/crn, uracil/crn, and carbamyl-β-alanine/crn (p = 0.03, 1.4 × 10 and 0.003, respectively). The values of urate/crn, xanthine/crn, uracil/crn, and carbamyl-β-alanine/crn were higher in females above 16 years of age. Ketosis and pH influenced some markers. In conclusion, decreased renal function interferes with the excretion of urinary purines and pyrimidines, and this could change decision limits substantially, e.g. result in false negative results in Lesch-Nyhan syndrome. SYNOPSIS: GFR influences purines and pyrimidines in urine. Clinical Trial Registration: ClinicalTrials.gov, Identifier NCT01092260, https://clinicaltrials.gov/ct2/show/NCT01092260?term=tondel&rank=2.
肾小球滤过率(GFR)常用于慢性肾脏病的诊断和随访。代谢缺陷(IEM)的筛查基于尿液中生物标志物的分析,这些标志物通过与尿肌酐(crn)的比值来报告。肾功能受损可能会使用于 IEM 筛查的几种生物标志物的解释复杂化。我们的目标是研究肾脏功能(以测量肾小球滤过率(mGFR)表示)对尿液中嘌呤和嘧啶的影响,以及与性别、年龄、pH 值和酮症的关系。纳入了不同 CKD 阶段的慢性肾脏病(CKD)患儿(n=96)。在注射碘海醇前采集尿液样本。使用 7 个时间点的血清样本基于碘海醇血浆清除率计算 mGFR。在 2015 年至 2021 年的实验室生产样本中检查了与性别、年龄、酮症和 pH 值的关联(n=8192)。年龄是所有标志物的高度显著协变量。GFR 与几种嘌呤和嘧啶呈正相关;黄嘌呤/crn、黄嘌呤/crn 和尿酸/crn 的比值(p=2.0×10、<3×10 和 7.2×10,分别),以及乳清酸/crn、尿嘧啶/crn 和氨甲酰-β-丙氨酸/crn 的比值(p=0.03、1.4×10 和 0.003,分别)。16 岁以上女性的尿酸/crn、黄嘌呤/crn、尿嘧啶/crn 和氨甲酰-β-丙氨酸/crn 值较高。酮症和 pH 值影响了一些标志物。总之,肾功能下降会干扰尿液中嘌呤和嘧啶的排泄,这可能会大大改变决策限值,例如导致 Lesch-Nyhan 综合征的假阴性结果。摘要:GFR 会影响尿液中的嘌呤和嘧啶。临床试验注册:ClinicalTrials.gov,标识符 NCT01092260,https://clinicaltrials.gov/ct2/show/NCT01092260?term=tondel&rank=2。